Phase 3 Trial Demonstrating High Efficacy, Favourable Safety, and Convenience of a Novel Calcipotriene and Betamethasone Dipropionate Cream. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s128. https://doi.org/10.25251/skin.7.supp.128